NEW YORK (GenomeWeb) – Genetic Technologies said it has raised A$18.6 million (US$14.3 million) after securing commitments from US investors. 

The Australian molecular diagnostics firm is offering 499,999,950 shares of its common stock, represented by 3,333,333 American Depositary Shares, with each ADS representing 150 ordinary shares of Genetic Technologies' shares. The firm is selling the securities directly to US investors. Maxim Group is the placement agent for the offering. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.